Cesarean pre-op medication advice

- Beth Ann Clayton, DNP CRNA, urged detailed preoperative planning for cesarean deliveries focused on medication continuity. - She recommended maintaining patients on methadone or Subutex rather than stopping those therapies before surgery. - Her guidance underscores the role of medication reconciliation and coordinated perioperative planning in obstetric anesthesia. (contemporaryobgyn.net)

A cesarean patient taking methadone or Subutex should usually stay on that medication before surgery, nurse anesthetist Beth Ann Clayton said in an April 18 interview. (contemporaryobgyn.net) Clayton, a doctor of nursing practice and certified registered nurse anesthetist, said preoperative planning for cesarean delivery starts with a full medication review rather than a last-minute chart check. She said anesthesia teams need to know which drugs a patient takes, when the last dose was taken, and which conditions could affect pain control or surgical safety. (contemporaryobgyn.net) Methadone and buprenorphine are medications for opioid use disorder, and Subutex is a brand name for buprenorphine. The Centers for Disease Control and Prevention says methadone and buprenorphine are recommended treatments for pregnant women with opioid use disorder. (cdc.gov) The American College of Obstetricians and Gynecologists says opioid agonist therapy is preferable to withdrawal during pregnancy because withdrawal is linked to high relapse rates and worse outcomes. Its guidance identifies methadone and buprenorphine as standard treatment options during pregnancy. (acog.org) That makes the pre-op question practical as much as philosophical: stopping a maintenance drug can leave a patient in withdrawal, in pain, or both when a cesarean is already a major abdominal operation. A 2024 multidisciplinary consensus statement from the Society for Obstetric Anesthesia and Perinatology, the Society for Maternal-Fetal Medicine, and the American Society of Regional Anesthesia and Pain Medicine said care should cover prenatal planning, cesarean anesthesia, and post-cesarean pain management for pregnant patients with opioid use disorder. (ajog.org) The same consensus statement said medication management for opioid use disorder belongs inside that obstetric pain plan, not outside it. The document was issued jointly by three specialty groups that write guidance for anesthesiologists, maternal-fetal medicine physicians, and pain specialists. (soap.org) Evidence from cesarean patients already maintained on methadone or buprenorphine shows these patients often need more pain medicine after surgery than other patients. A retrospective study published in 2021 found higher postoperative opioid use and higher pain scores in both groups, which supports planning ahead instead of assuming standard dosing will work. (ncbi.nlm.nih.gov) Clayton’s advice also fits newer American Society of Anesthesiologists guidance on pain during cesarean delivery, which calls for structured planning and multiple pain-control methods during surgery. The society’s 2024 statement focuses on recognizing pain early and treating it with layered approaches rather than relying on a single drug. (asahq.org) For obstetric teams, the takeaway is operational: reconcile medications early, confirm maintenance therapy, and build the anesthesia plan around the patient who is actually arriving in the operating room. Clayton said that work should happen before incision time, not after pain control starts to fail. (contemporaryobgyn.net)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.